By: Benzinga
Volatility Continues in Affymax; Stock Jumps 22%
Over the last month, shares of biotech firm Affymax (NASDAQ: AFFY ) have lost around 92 percent of their value. The company currently has a market cap of under $50 million. The catalyst for the plunge in the stock price was the recall of the company's only marketed product
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here